Then on the order of IL-38+/CD138+ plasmacytes, IL-38+/CD3+ T cell, IL-38+/CD68+ macrophages, and IL-38+/CD20+ B cells, which were 1.80, 1.27, 0.88 and 0.61 per filed in prostate cancer tumour and mesenchyme. This evidence concerns the gene CD68 and prostate carcinoma.